Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Corea y enfermedad de Huntington

450 ARTíCULOS , VIENDO DEL 301 AL 315

PUBMED

Direct evidence of progressive cardiac dysfunction in a transgenic mouse model of Huntington's disease.

Wood NI, Sawiak SJ, Buonincontri G, Niu Y, Kane AD, Carpenter TA, Giussani DA, Morton AJ.

J Huntingtons Dis. 2012;1(1):57-64. doi: 10.3233/JHD-2012-120004.

0

0

0

PUBMED

Chorea as the first and only manifestation of systemic lupus erythematosus.

Poil AR, Yousef Khan F, Lutf A, Hammoudeh M.

Case Rep Rheumatol. 2012;2012:907402.

0

0

0

PUBMED

α-Synuclein levels modulate Huntington's disease in mice.

Corrochano S, Renna M, Carter S, Chrobot N, Kent R, Stewart M, Cooper J, Brown SD, Rubinsztein DC, Acevedo-Arozena A.

Hum Mol Genet. 2012 Feb 1;21(3):485-94. doi: 10.1093/hmg/ddr477. Erratum in: Hum Mol Genet. 2012 Dec 1;21(23):5237.

0

0

0

PUBMED

Selective neurodegeneration, neuropathology and symptom profiles in Huntington's disease.

Waldvogel HJ, Thu D, Hogg V, Tippett L, Faull RL.

Adv Exp Med Biol. 2012;769:141-52. Review.

0

0

0

PUBMED

Acute, sustained chorea in children after supratherapeutic dosing of amphetamine-derived medications.

Ford JB, Albertson TE, Owen KP, Sutter ME, McKinney WB.

Pediatr Neurol. 2012 Sep;47(3):216-8. doi: 10.1016/j.pediatrneurol.2012.05.013.

0

0

0

PUBMED

trans-(-)-ε-Viniferin increases mitochondrial sirtuin 3 (SIRT3), activates AMP-activated protein kinase (AMPK), and protects cells in models of Huntington Disease.

Fu J, Jin J, Cichewicz RH, Hageman SA, Ellis TK, Xiang L, Peng Q, Jiang M, Arbez N, Hotaling K, Ross CA, Duan W.

J Biol Chem. 2012 Jul 13;287(29):24460-72. doi: 10.1074/jbc.M112.382226.

0

0

0

PUBMED

RNAi-based therapies for Huntington's disease: delivery challenges and opportunities.

Mantha N, Das SK, Das NG.

Ther Deliv. 2012 Sep;3(9):1061-76. Review.

0

0

0

PUBMED

Serum levels of N-acetylaspartate in Huntington's disease: preliminary results.

Ruggieri M, Serpino C, Ceci E, Sciruicchio V, Franco G, Pica C, Trojano M, Livrea P, de Tommaso M.

Mov Disord. 2012 Feb;27(2):329-30. doi: 10.1002/mds.23974. No abstract available.

0

0

0

PUBMED

Evaluation of multi-modal, multi-site neuroimaging measures in Huntington's disease: Baseline results from the PADDINGTON study.

Hobbs NZ, Cole JH, Farmer RE, Rees EM, Crawford HE, Malone IB, Roos RA, Sprengelmeyer R, Durr A, Landwehrmeyer B, Scahill RI, Tabrizi SJ, Frost C.

Neuroimage Clin. 2012 Dec 9;2:204-11. doi: 10.1016/j.nicl.2012.12.001.

0

0

0

PUBMED

A pathogenic mechanism in Huntington's disease involves small CAG-repeated RNAs with neurotoxic activity.

Bañez-Coronel M, Porta S, Kagerbauer B, Mateu-Huertas E, Pantano L, Ferrer I, Guzmán M, Estivill X, Martí E.

PLoS Genet. 2012;8(2):e1002481. doi: 10.1371/journal.pgen.1002481.

0

0

0

PUBMED

Abnormal apocrine secretory cell mitochondria in a Huntington disease patient.

Sidiropoulos C, LeWitt P, Hashimoto K.

J Neurol Sci. 2012 Dec 15;323(1-2):261-3. doi: 10.1016/j.jns.2012.08.034.

0

0

0

PUBMED

Patterns of serotonergic antidepressant usage in prodromal Huntington disease.

Rowe KC, Paulsen JS, Langbehn DR, Wang C, Mills J, Beglinger LJ, Smith MM, Epping EA, Fiedorowicz JG, Duff K, Ruggle A, Moser DJ; PREDICT-HD Investigators of the Huntington Study Group..

Psychiatry Res. 2012 Apr 30;196(2-3):309-14. doi: 10.1016/j.psychres.2011.09.005.

0

0

0

PUBMED

P38 MAPK is involved in enhanced NMDA receptor-dependent excitotoxicity in YAC transgenic mouse model of Huntington disease.

Fan J, Gladding CM, Wang L, Zhang LY, Kaufman AM, Milnerwood AJ, Raymond LA.

Neurobiol Dis. 2012 Mar;45(3):999-1009. doi: 10.1016/j.nbd.2011.12.019.

0

0

0

PUBMED

Magnetization transfer imaging in premanifest and manifest Huntington disease.

van den Bogaard SJ, Dumas EM, Milles J, Reilmann R, Stout JC, Craufurd D, van Buchem MA, van der Grond J, Roos RA.

AJNR Am J Neuroradiol. 2012 May;33(5):884-9. doi: 10.3174/ajnr.A2868.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy